Guideline Resources
Dev Hip Dysplasia in Infants <6 mo: Detection + Nonoperative Mgmt | 2014 AAOS Guideline
Key Points
Screening pts w/ risk factors (breech presentation, FHx, clinical instability hx) is supported by mod evidence: either US @ age 2-6 wk or x-ray @ age 4 mo. Approx 60%-80% of abnormalities identified by exam and >90% identified by US appear to resolve spontaneously in early infancy.
Choose Patient Type
American Academy of Orthopaedic Surgeon. Detection and Nonoperative Management of Pediatric Developmental Dysplasia of the Hip in Infants Up to Six Months of Age: Evidence-based Clinical Practice Guideline. Adopted September 5, 2014.
Epocrates Guideline Synopsis Last Update: Apr 24, 2017
Publication Year:
2014
Source:
AAOS - American Academy of Orthopaedic Surgeons
Endorsed By:
American Academy of Pediatrics, Pediatric Orthopaedic Society of North America, Society of Diagnostic Medical Sonography, Society for Pediatric Radiology
Recommendation Strength
[S] Strong (≥2 high-strength studies w/ consistent findings)
[M] Moderate (≥2 mod-strength studies w/ consistent findings or 1 high-quality study)
[L] Limited (low/conflicting; ≥2 low-strength studies w/ consistent findings or 1 mod-quality study; or insufficent/conflicting EV)
[C] Consensus opinion in absence of reliable EV
Abbreviations
AAOS American Academy of Orthopaedic Surgeons
abnl abnormal
AP anterior posterior
AVN avascular necrosis
DDH developmental dysplasia hip
EV evidence
f/u follow-up
NL normal
US ultrasound